The increased risk of the combined cardiovascular outcome in the highest adiponectin quartile (adjusted OR 1.7 [95% CI 0.9-3.1]) was primarily driven by all-cause mortality, as there were no strong associations between adiponectin and myocardial infarction/PCI or stroke. This evidence concerns the gene ADIPOQ and Stroke.